What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
For example, B12 shots of 25-50 mg doses (nearly a whole monthly vial of ours) have been used to treat cyanide poisoning, neuropathy, and ALS
Capsules may appeal to patients who want convenience, while injections are often discussed for more direct delivery
In addition to the total score, the questionnaire was divided into an autonomic component (questions 25, 9, 1116) and a pain component (questions 1, 68, 1721) to assess those dimensions of the patients neuropathic symptoms
We provide personalized peptide therapy protocols with experienced medical providers
